|
Volumn 43, Issue 9, 2002, Pages 1837-1842
|
Favorable impact of virological response to highly active antiretroviral therapy on survival in patients with AIDS-related lymphoma
a a a b b c,d a a a a a |
Author keywords
AIDS related lymphoma; HAART; Prognosis; Virological response
|
Indexed keywords
ANTIRETROVIRUS AGENT;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DIDANOSINE;
DOXORUBICIN;
HYDROCORTISONE;
INDINAVIR;
LACTATE DEHYDROGENASE;
LAMIVUDINE;
METHOTREXATE;
NELFINAVIR;
PENTAMIDINE;
PREDNISONE;
RITONAVIR;
SAQUINAVIR;
STAVUDINE;
VINCRISTINE;
ZALCITABINE;
ZIDOVUDINE;
AIDS RELATED COMPLEX;
ARTICLE;
CANCER PATIENT;
CANCER SURVIVAL;
CONTROLLED STUDY;
DRUG RESPONSE;
FEMALE;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
LACTATE DEHYDROGENASE BLOOD LEVEL;
LYMPHOMA;
MAJOR CLINICAL STUDY;
MALE;
MULTIVARIATE ANALYSIS;
PRIORITY JOURNAL;
PROGNOSIS;
RETROSPECTIVE STUDY;
STATISTICAL SIGNIFICANCE;
SURVIVAL TIME;
VIRUS INFECTION;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
CYCLOPHOSPHAMIDE;
DISEASE-FREE SURVIVAL;
DOXORUBICIN;
FEMALE;
HUMANS;
L-LACTATE DEHYDROGENASE;
LYMPHOMA, AIDS-RELATED;
MALE;
MIDDLE AGED;
MULTIVARIATE ANALYSIS;
PREDNISONE;
PROGNOSIS;
TIME FACTORS;
TREATMENT OUTCOME;
VINCRISTINE;
|
EID: 6444245767
PISSN: 10428194
EISSN: None
Source Type: Journal
DOI: 10.1080/1042819021000006402 Document Type: Article |
Times cited : (19)
|
References (27)
|